These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3191209

  • 1. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
    Ben-David M, Wittliff JL, Fekete M, Kadar T, Biran S, Schally AV.
    Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
    [Abstract] [Full Text] [Related]

  • 2. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR, Willekes-Koolschijn N, Bevers MM, Van der Gugten AA, Misdorp W.
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [Abstract] [Full Text] [Related]

  • 3. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M, Fazzuoli L, Bernasconi D, Berta S, Giordano G.
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
    Waseda N, Kato Y, Imura H, Kurata M.
    Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
    [Abstract] [Full Text] [Related]

  • 5. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS, Charreau EH, Royer de Giaroli M, Baldi A.
    Prog Clin Biol Res; 1984 Jun; 142():97-108. PubMed ID: 6709661
    [Abstract] [Full Text] [Related]

  • 6. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J, Klijn JG.
    Cancer Res; 1989 Nov 01; 49(21):5823-8. PubMed ID: 2676151
    [Abstract] [Full Text] [Related]

  • 8. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y, Tashiro H, Hisamatsu K, Shinozuka K.
    Anticancer Res; 1988 Nov 01; 8(4):647-51. PubMed ID: 2972248
    [Abstract] [Full Text] [Related]

  • 9. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer.
    Bonneterre J, Peyrat JP, Beuscart R, Demaille A.
    Eur J Cancer Clin Oncol; 1986 Nov 01; 22(11):1331-6. PubMed ID: 3830215
    [Abstract] [Full Text] [Related]

  • 10. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, International Breast Cancer Study Group.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1571-81. PubMed ID: 17077359
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA, Huguet J, Valero J, Samaniego JM, Rosel P, Sirvent JJ.
    Med Clin (Barc); 1991 Jun 08; 97(2):41-4. PubMed ID: 1895780
    [Abstract] [Full Text] [Related]

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 08; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment.
    Ben-David M, Kadar T, Wittliff J, Biran S, Schally A.
    Biomed Pharmacother; 1988 Jun 08; 42(2):101-9. PubMed ID: 3167163
    [Abstract] [Full Text] [Related]

  • 15. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
    Pekonen F, Partanen S, Mäkinen T, Rutanen EM.
    Cancer Res; 1988 Mar 01; 48(5):1343-7. PubMed ID: 2963690
    [Abstract] [Full Text] [Related]

  • 16. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM.
    Cancer Res; 1987 Apr 01; 47(7):1830-5. PubMed ID: 3545455
    [Abstract] [Full Text] [Related]

  • 17. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.